Correction: Does the chemotherapy backbone impact on the efficacy of targeted agents in metastatic colorectal cancer? A systematic review and meta-analysis of the literature

David L. Chan; Nick Pavlakis; Jeremy Shapiro; Timothy J. Price; Christos S. Karapetis; Niall C. Tebbutt; Eva Segelov

doi:10.1371/journal.pone.0138916

Correction: Does the chemotherapy backbone impact on the efficacy of targeted agents in metastatic colorectal cancer? A systematic review and meta-analysis of the literature

David L. Chan, Nick Pavlakis, Jeremy Shapiro, Timothy J. Price, Christos S. Karapetis, Niall C. Tebbutt, Eva Segelov

College of Medicine and Public Health

Research output: Contribution to journal › Comment/debate

4 Citations (Scopus)

16 Downloads (Pure)

Abstract

(PLoS ONE (2015) 10:8 (e0135599) DOI: 10.1371/journal. pone.0135599)
There is an error in reference 22. The correct reference is: Peeters M, Price TJ, Cervantes A,Sobrero AF, Ducreux M, Hotko Y, et al. Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer. J Clin Oncol. 2010 Nov 1;28(31):4706-13.Fig 5is incorrect. The authors have provided a corrected version here.

Original language	English
Article number	e0138916
Number of pages	1
Journal	PLoS One
Volume	10
Issue number	9
DOIs	https://doi.org/10.1371/journal.pone.0138916
Publication status	Published - 25 Sept 2015

Bibliographical note

Copyright:© 2015 Chan et al. This is an openaccess article distributed under the terms of theCreative Commons Attribution License, which permitsunrestricted use, distribution, and reproduction in anymedium, provided the original author and source arecredited

Keywords

cancer
chemotherapy
colorectal cancer

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1371/journal.pone.0138916Licence: CC BY

Correction_Chan_P2015Final published version, 393 KBLicence: CC BY

Cite this

@article{f944b66984c348c6a4aaa38afef504ea,

title = "Correction: Does the chemotherapy backbone impact on the efficacy of targeted agents in metastatic colorectal cancer? A systematic review and meta-analysis of the literature",

abstract = " (PLoS ONE (2015) 10:8 (e0135599) DOI: 10.1371/journal. pone.0135599)There is an error in reference 22. The correct reference is: Peeters M, Price TJ, Cervantes A,Sobrero AF, Ducreux M, Hotko Y, et al. Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer. J Clin Oncol. 2010 Nov 1;28(31):4706-13.Fig 5is incorrect. The authors have provided a corrected version here.",

keywords = "cancer, chemotherapy, colorectal cancer",

author = "Chan, {David L.} and Nick Pavlakis and Jeremy Shapiro and Price, {Timothy J.} and Karapetis, {Christos S.} and Tebbutt, {Niall C.} and Eva Segelov",

note = "Copyright:{\textcopyright} 2015 Chan et al. This is an openaccess article distributed under the terms of theCreative Commons Attribution License, which permitsunrestricted use, distribution, and reproduction in anymedium, provided the original author and source arecredited",

year = "2015",

month = sep,

day = "25",

doi = "10.1371/journal.pone.0138916",

language = "English",

volume = "10",

journal = "PLoS One",

issn = "1932-6203",

publisher = "PlosOne",

number = "9",

}

TY - JOUR

T1 - Correction

T2 - Does the chemotherapy backbone impact on the efficacy of targeted agents in metastatic colorectal cancer? A systematic review and meta-analysis of the literature

AU - Chan, David L.

AU - Pavlakis, Nick

AU - Shapiro, Jeremy

AU - Price, Timothy J.

AU - Karapetis, Christos S.

AU - Tebbutt, Niall C.

AU - Segelov, Eva

N1 - Copyright:© 2015 Chan et al. This is an openaccess article distributed under the terms of theCreative Commons Attribution License, which permitsunrestricted use, distribution, and reproduction in anymedium, provided the original author and source arecredited

PY - 2015/9/25

Y1 - 2015/9/25

N2 - (PLoS ONE (2015) 10:8 (e0135599) DOI: 10.1371/journal. pone.0135599)There is an error in reference 22. The correct reference is: Peeters M, Price TJ, Cervantes A,Sobrero AF, Ducreux M, Hotko Y, et al. Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer. J Clin Oncol. 2010 Nov 1;28(31):4706-13.Fig 5is incorrect. The authors have provided a corrected version here.

AB - (PLoS ONE (2015) 10:8 (e0135599) DOI: 10.1371/journal. pone.0135599)There is an error in reference 22. The correct reference is: Peeters M, Price TJ, Cervantes A,Sobrero AF, Ducreux M, Hotko Y, et al. Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer. J Clin Oncol. 2010 Nov 1;28(31):4706-13.Fig 5is incorrect. The authors have provided a corrected version here.

KW - cancer

KW - chemotherapy

KW - colorectal cancer

UR - http://www.scopus.com/inward/record.url?scp=84947290716&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0138916

DO - 10.1371/journal.pone.0138916

M3 - Comment/debate

AN - SCOPUS:84947290716

SN - 1932-6203

VL - 10

JO - PLoS One

JF - PLoS One

IS - 9

M1 - e0138916

ER -

Correction: Does the chemotherapy backbone impact on the efficacy of targeted agents in metastatic colorectal cancer? A systematic review and meta-analysis of the literature

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this